Biomedical device company Biotronik is touting a study demonstrating that its ProMRI pacemakers can be safely used in MRI. The study was presented at the American College of Cardiology (ACC) annual meeting in San Diego.
The results show ProMRI to be free of significant threshold increases, significant decreases in amplitude, and serious adverse effects one month after MRI scans were performed. In total, 203 patients enrolled in the ProMRI phase B study underwent full-body MRI scans, including cardiac and thoracic spinal scans, without an exclusion zone.
The researchers also analyzed the scans for image artifacts and found that 96.1% had none or contained an artifact that did not affect diagnostic image quality.
